2,521 Shares in HealthEquity, Inc. (NASDAQ:HQY) Purchased by Curated Wealth Partners LLC

Curated Wealth Partners LLC bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,521 shares of the company's stock, valued at approximately $242,000.

Other hedge funds also recently made changes to their positions in the company. Wasatch Advisors LP increased its position in HealthEquity by 6.6% in the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company's stock worth $635,065,000 after buying an additional 483,269 shares during the last quarter. Mackenzie Financial Corp raised its stake in HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company's stock valued at $203,822,000 after acquiring an additional 325,906 shares during the period. Vaughan Nelson Investment Management L.P. lifted its holdings in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock valued at $69,034,000 after purchasing an additional 226,563 shares during the last quarter. Barclays PLC boosted its position in HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company's stock worth $13,628,000 after purchasing an additional 112,667 shares during the period. Finally, Thrivent Financial for Lutherans increased its stake in shares of HealthEquity by 33.3% in the third quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company's stock worth $24,033,000 after purchasing an additional 73,404 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

HQY has been the subject of several analyst reports. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. Barrington Research raised their price target on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. BTIG Research boosted their price objective on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. JMP Securities increased their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. Finally, Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $110.71.

HealthEquity Price Performance

HQY traded up $2.17 during trading on Friday, reaching $106.88. The stock had a trading volume of 654,597 shares, compared to its average volume of 607,718. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business has a 50-day moving average of $99.60 and a 200-day moving average of $87.35. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $107.87. The stock has a market cap of $9.26 billion, a PE ratio of 98.06, a PEG ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the business posted $0.40 earnings per share. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Activity

In related news, Director Robert W. Selander sold 8,250 shares of the business's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the transaction, the director now owns 66,469 shares in the company, valued at $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company's stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,289 shares of company stock valued at $3,355,718. Insiders own 2.20% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.